Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
20041.8k citationsStevo Julius, Sverre E. Kjeldsen et al.profile →
Essential Hypertension: Renin and Aldosterone, Heart Attack and Stroke
Countries citing papers authored by Hans R. Brunner
Since
Specialization
Citations
This map shows the geographic impact of Hans R. Brunner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans R. Brunner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans R. Brunner more than expected).
This network shows the impact of papers produced by Hans R. Brunner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans R. Brunner. The network helps show where Hans R. Brunner may publish in the future.
Co-authorship network of co-authors of Hans R. Brunner
This figure shows the co-authorship network connecting the top 25 collaborators of Hans R. Brunner.
A scholar is included among the top collaborators of Hans R. Brunner based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Hans R. Brunner. Hans R. Brunner is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Waeber, Bernard, Raimar Weber, & Hans R. Brunner. (1995). Physiopathologie de l'hypertrophie ventriculaire gauche.. Archives Des Maladies Du Coeur Et Des Vaisseaux. 88. 9–14.1 indexed citations
8.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1993). Control of vascular tone by renin and angiotensin in cardiovascular disease.. PubMed. 14 Suppl I. 149–53.8 indexed citations
9.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1993). Inhibitors of the renin-angiotensin system.. PubMed. 43(2A). 274–8.6 indexed citations
10.
Brunner, Hans R., J. Nussberger, & B. Waeber. (1993). Angiotensin II blockade compared with other pharmacological methods of inhibiting the renin-angiotensin system.. PubMed. 11(3). S53–8.26 indexed citations
Brunner, Hans R., J. Nussberger, & B. Waeber. (1990). Various approaches to blockade of the renin-angiotensin system: persistent renin response.. PubMed. 8(7). S149–53.4 indexed citations
Gavras, Haralambos, Haralambos Gavras, Hans R. Brunner, & Chang‐seng Liang. (1979). Antihypertensive action of beta-adrenoceptor blockade and the renin-angiotensin system.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 7 Suppl 2. 213S–217S.4 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.